PHR — Pharmena SA Cashflow Statement
0.000.00%
- PLN33.30m
- PLN27.69m
- PLN1.58m
Annual cashflow statement for Pharmena SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.46 | -1.41 | -12 | -2.56 | -2.74 |
| Depreciation | |||||
| Non-Cash Items | 0.174 | 0.731 | 46.7 | -0.865 | -0.535 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.432 | 1.94 | -4.3 | 0.796 | -0.135 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.23 | 1.82 | 30.8 | -2.53 | -3.29 |
| Capital Expenditures | -0.319 | -0.226 | -1.3 | -0.18 | -0.237 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.071 | 0.007 | 0.409 | -8.18 | 2.24 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.248 | -0.219 | -0.892 | -8.36 | 2 |
| Financing Cash Flow Items | -1.07 | -0.812 | -0.859 | -0.015 | -0.021 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.21 | -1.47 | -9.22 | -9.54 | -0.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.259 | 0.132 | 20.7 | -20.4 | -1.39 |